Julia Billigen

Clinical Outcomes of Transplanted Modified Bone Marrow–Derived Mesenchymal Stem Cells in Stroke

Gary K. Steinberg, Douglas Kondziolka, Lawrence R. Wechsler et al. · Stroke · 2016 · 382 citations · Full text

Long-term outcome in traumatic brain injury patients with midline shift: a secondary analysis of the Phase 3 COBRIT clinical trial

Ross C. Puffer, John K. Yue, Matthew Mesley et al. · Journal of neurosurgery · 2018 · 36 citations

Recovery Trajectories and Long-Term Outcomes in Traumatic Brain Injury: A Secondary Analysis of the Phase 3 Citicoline Brain Injury Treatment Clinical Trial

Ross C. Puffer, John K. Yue, Matthew Mesley et al. · World Neurosurgery · 2019 · 14 citations

Recovery Trajectories, Cognitive Rehabilitation, Traumatic Brain Injury +15

Increased Cerebral Oxygen Metabolism and Ischemic Stress in Subjects with Metabolic Syndrome-Associated Risk Factors: Preliminary Observations

Ken Uchino, Ridwan Lin, Syed Zaidi et al. · Translational Stroke Research · 2010 · 12 citations

Metabolic Disorder, Cerebral Vascular Regulation, Obesity +16

Abstract 149: A Novel Phase 1/2A Study of Intraparenchymal Transplantation of Human Modified Bone Marrow Derived Cells in Patients with Stable Ischemic Stroke

Gary K. Steinberg, Douglas Kondziolka, Neil Schwartz et al. · Stroke · 2014 · 10 citations

Cell Therapy, Stable Ischemic Stroke, Cerebrovascular Disease +27